![JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients](https://pub.mdpi-res.com/jpm/jpm-12-01307/article_deploy/html/images/jpm-12-01307-g004.png?1660308975)
JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients
![Pharmacie Parent SPRL : Home > Substances actives - F - Finastéride - FINASTERIDE TEVA 5 MG 100 COMP Pharmacie Parent SPRL : Home > Substances actives - F - Finastéride - FINASTERIDE TEVA 5 MG 100 COMP](https://www.pharmacieparent.be/UserFiles/Uploads/images/Products/2564235.jpg)
Pharmacie Parent SPRL : Home > Substances actives - F - Finastéride - FINASTERIDE TEVA 5 MG 100 COMP
![JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients](https://pub.mdpi-res.com/jpm/jpm-12-01307/article_deploy/html/images/jpm-12-01307-g002.png?1660308973)
JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients
![JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients](https://pub.mdpi-res.com/jpm/jpm-12-01307/article_deploy/html/images/jpm-12-01307-ag.png?1660308978)
JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients
![JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients](https://pub.mdpi-res.com/jpm/jpm-12-01307/article_deploy/html/images/jpm-12-01307-g005.png?1660308977)